Manufacturer

AstraZeneca GLP-1 medications

GLP-1 medications from AstraZeneca, with sourced prices, shortage reports and study results.

Last checked · Oct 3, 2026 UTC

1approved

Approved medicines

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

GLP-1

Exenatide

Byetta (discontinued), Bydureon BCise (discontinued), Generic exenatide

Subcutaneous injection · Twice daily (Byetta); once weekly (Bydureon BCise)

FDA shortage report

Published entry quote

~$447 per pen

Generic exenatide (Amneal) · GoodRx

Checked Sep 30, 2026

Price conditions

GoodRx coupon, lowest listed price for one 5 mcg pen (60 doses: 30 days at the twice-daily dose)

AstraZeneca discontinued both branded products in 2024 (Byetta and Bydureon BCise), and Byetta's approval was withdrawn in 2025. Only generic exenatide (Amneal) remains; residual branded stock may still appear at the pharmacy.

Third-party reported price.

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.